Letter to the Editor

Leukemia (2009) 23, 1171–1174; doi:10.1038/leu.2008.401; published online 5 February 2009

Reduced-intensity allogeneic transplantation combined with imatinib mesylate for chronic myeloid leukemia in first chronic phase

Y Luo1,2, X-Y Lai1,2, Y-M Tan1, J-M Shi1, Y-M Zhao1, X-Y Han1, G-F Zheng1, X-L Zhu1, J Sun1, Y-L Zheng1, G-Q Wu1, J-S He1, S-Y Chen1, A-Y Jin1, W-Z Xie1, X-J Ye1, Z Cai1, M-F Lin1 and H Huang1

1Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China

Correspondence: H Huang, E-mail: hehuang.zju@gmail.com

2These authors contributed equally to this work.

Extra navigation

.

naturejobs

More science jobs
Post a job for free
ADVERTISEMENT